MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program
(marketscreener.com)
TORONTO, Dec. 22, 2023 /PRNewswire/ – MediPharm Labs Corp. a pharmaceutical company specialized in precision-based cannabinoids, today announced an update regarding its Board of Directors and employee stock issuance.
……
TORONTO, Dec. 22, 2023 /PRNewswire/ – MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-bas…